This document summarizes a recombinant monoclonal antibody that targets CEACAM5, a potential cancer treatment. It is a single domain antibody derived from a llama VHH library against the extracellular region of human CEACAM5. The antibody is intended for research use only and not for diagnostic or therapeutic human use.